The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy

Authors: Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal, Oguzcan Kinikoglu, Sila Oksuz, Ugur Ozkerim, Salih Tunbekici, Hacer Sahika Yildiz, Ozkan Alan, Sermin Coban Kokten, Deniz Isik, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabas, Mahmut Emre Yildirim, Nedim Turan

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)

Subject Terms: Early breast cancer, Neoadjuvant chemotherapy, Laboratory index, Pathologic complete response, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/1a1cba80adca4b45bbb0a31a1f079759

Efficacy and Clinical Outcomes of Crizotinib in Patients with ROS1-Rearranged NSCLC: A Multicenter Study

Authors: Alper Topal, Goncagul Akdag, Sedat Yildirim, Oguzcan Kinikoglu, Deniz Isik, Gizem Yildirim, Salih Tunbekici, Fatih Kus, Aydın Acarbay, Murad Guliyev, Nargiz Majidova, Yasin Kutlu, Mustafa Erman, Hatice Odabas, Nedim Turan, Nuri Karadurmus

Source: Medicina, Vol 61, Iss 3, p 490 (2025)

Subject Terms: ROS1, lung cancer, crizotinib, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/61/3/490; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/b43b14acd3404ea29fba10ebc5c5f9b8

Association of Hepatitis-B virus infection status with survival and treatment response in non-small cell lung cancer patients on anti‐pd‐1/pd-l1 therapy

Authors: Eda Alp, Goncagul Akdag Topal, DENİZ IŞIK, Nedim Turan

Source: Journal of Global Antimicrobial Resistance, Vol 39, Iss , Pp 76-77 (2024)

Subject Terms: HBV reactivation,Anti-HBc,Nivolumab,immune checkpoint inhibitors,Anti-PD-1/PD-L1 therapy, Microbiology, QR1-502

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2213716524004259; https://doaj.org/toc/2213-7165

Access URL: https://doaj.org/article/9ee810b286334ea2a22e01c39f48bf86

Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases

Authors: Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur

Source: Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)

Subject Terms: Oncogene-driven advanced non-small cell lung cancer, De novo brain metastases, Survival related parameters, Medicine, Science

File Description: electronic resource

Relation: https://doaj.org/toc/2045-2322

Access URL: https://doaj.org/article/dfd4fc84465f4b4985707fa241e217b7

Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study

Authors: Akif Doğan, Nurullah İlhan, Goncagül Akdağ, Sedat Yıldırım, Mustafa Seyyar, Zeynep Yüksel Yaşar, Hande Nur Erölmez, Heves Sürmeli, Buğra Öztosun, Özlem Nuray Sever, Hatice Odabaş, Mahmut Emre Yıldırım, Devrim Çabuk, Nedim Turan, Mahmut Gümüş

Source: Medicina, Vol 61, Iss 1, p 154 (2025)

Subject Terms: early-onset breast cancer, very early-onset breast cancer, CDK 4/6 inhibitors, premenopausal metastatic breast cancer, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/61/1/154; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/087849adf31c4dea8bc2d03dfd9f5447

Trastuzumab Rechallenge in HER2-Positive Metastatic Breast Cancer: A Promising Strategy for Enhanced Progression-Free Survival Post Ado-Trastuzumab Emtansine Progression

Authors: Yunus Emre Altıntaş, Oğuzcan Kınıkoğlu, Anıl Yıldız, Deniz Işık, Uğur Özkerim, Sıla Öksüz, Tuğba Başoğlu Tüylü, Heves Sürmeli, Nedim Turan, Hatice Odabaş

Source: Medicina, Vol 60, Iss 12, p 2069 (2024)

Subject Terms: HER2-positive breast cancer, trastuzumab re-challenge, lapatinib capecitabine, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/12/2069; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/06488f0944de4dfca4094aa2613c7846

Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?

Authors: Goncagul Akdag, Deniz Isik, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Alper Topal, Sila Oksuz, Ezgi Turkoglu, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Hatice Odabas, Mahmut Emre Yildirim, Nedim Turan

Source: Medicina, Vol 60, Iss 8, p 1372 (2024)

Subject Terms: colon cancer, T4N0 stage, adjuvant treatment, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/8/1372; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/6320822833324fba8255b91244490237

Prognostic Impact and Clinical Features of Spread through Air Spaces in Operated Lung Cancer: Real-World Analysis

Authors: Sedat Yildirim, Ozkan Alan, Zeynep Yuksel Yasar, Tugba Kaya, Goncagul Akdag, Oguzcan Kinikoglu, Gonca Gul Gecmen, Alper Yasar, Deniz Isik, Heves Surmeli, Tugba Basoglu, Ozlem Nuray Sever, Mahmut Emre Yildirim, Hatice Odabas, Nedim Turan

Source: Medicina, Vol 60, Iss 8, p 1374 (2024)

Subject Terms: disease-free survival, non-small-cell lung cancer, overall survival, prognostic factor, tumor spread through air spaces, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/8/1374; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/448842896a04478c96a4f27fea588dd4

Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study

Authors: Goncagul Akdag, Özkan Alan, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Aziz Batu, Emre Kudu, Gonca Gül Geçmen, Deniz Isik, Ozlem Nuray Sever, Hatice Odabas, Mahmut Emre Yildirim, Nedim Turan

Source: Heliyon, Vol 10, Iss 3, Pp e25029- (2024)

Subject Terms: Pulmonary large cell neuroendocrine carcinoma, Platelet/ lymphocyte ratio, Modified glasgow prognostic score, Disease free survival, Overall survival, Science (General), Q1-390, Social sciences (General), H1-99

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2405844024010600; https://doaj.org/toc/2405-8440

Access URL: https://doaj.org/article/fe5ff27d70a34196bb445935ae17b83a

Clinical Effectiveness of Targeted Therapies Following Nivolumab Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-World Study

Authors: Deniz Işık, Oğuzcan Kınıkoğlu, Goncagül Akdağ, Yunus Emre Altıntaş, Ezgi Türkoğlu, Sedat Yildirim, Heves Sürmeli, Tuğba Başoğlu, Hatice Odabaş, Nedim Turan

Source: Medicina, Vol 60, Iss 7, p 1088 (2024)

Subject Terms: renal cell carcinoma, nivolumab, targeted therapy, efficacy and toxicity, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/7/1088; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/9b549c3d6d49476285fb0a85aad8e5af

Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer

Authors: Oğuzcan Kınıkoğlu, Hatice Odabas, Yunus Emre Altıntaş, Anıl Yıldız, Burçin Çakan, Goncagül Akdağ, Sedat Yıldırım, Hamit Bal, Tuğba Kaya, Salih Tünbekici, Deniz Işık, Tuğba Başoğlu, Mahmut Emre Yıldırım, Nedim Turan

Source: Medicina, Vol 60, Iss 6, p 951 (2024)

Subject Terms: metastatic breast cancer, trastuzumab emtansine, endocrine therapy, pertuzumab plus trastuzumab, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/60/6/951; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/6ffb7c6ff0a64dc68ddaa9958c580ba2

Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

Authors: Hatice Odabas, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim, Nedim Turan, Mahmut Emre Yildirim, Mahmut Gumus

Source: Medicina, Vol 59, Iss 3, p 557 (2023)

Subject Terms: metastatic breast cancer, palbociclib, ribociclib, proton pump inhibitors, drug-drug interactions, Medicine (General), R5-920

File Description: electronic resource

Relation: https://www.mdpi.com/1648-9144/59/3/557; https://doaj.org/toc/1010-660X; https://doaj.org/toc/1648-9144

Access URL: https://doaj.org/article/0e0b7c0de82c401fb9197cf40efeed4d

MRI AS A THERAPEUTIC DEVICE